Clinical Trial Update: Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Escherichia coli Nissle 1917 as supportive therapy to standard care for Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Escherichia coli Nissle 1917 (Escherichia coli Nissle 1917)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Diabetes Mellitus Type II | Phase 3 | Status: COMPLETED